Published in Cardiovasc Diabetol on October 23, 2013
Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor. Cardiovasc Diabetol (2014) 1.14
Clinical utility of brachial-ankle pulse wave velocity in the prediction of cardiovascular events in diabetic patients. Cardiovasc Diabetol (2014) 0.99
Treatment-dependent and treatment-independent risk factors associated with the risk of diabetes-related events: a retrospective analysis based on 229,042 patients with type 2 diabetes mellitus. Cardiovasc Diabetol (2015) 0.87
Subclinical vascular inflammation in subjects with normal weight obesity and its association with body fat: an 18 F-FDG-PET/CT study. Cardiovasc Diabetol (2014) 0.85
Comparison of 2-year mortality according to obesity in stabilized patients with type 2 diabetes mellitus after acute myocardial infarction: results from the DIAMOND prospective cohort registry. Cardiovasc Diabetol (2015) 0.82
Relationship of obesity and insulin resistance with the cerebrovascular reactivity: a case control study. Cardiovasc Diabetol (2014) 0.81
Gender differences in the progression of target organ damage in patients with increased insulin resistance: the LOD-DIABETES study. Cardiovasc Diabetol (2015) 0.80
Association between metabolic syndrome and multiple lesions of intracranial atherothrombotic stroke: a hospital-based study. Cardiovasc Diabetol (2015) 0.78
High levels of thyroid-stimulating hormone are associated with aortic wall thickness in the general population. Eur Radiol (2016) 0.77
Effectiveness of sulphonylureas in the therapy of diabetes mellitus type 2 patients: an observational cohort study. J Diabetes Metab Disord (2016) 0.75
The coexistence of carotid and lower extremity atherosclerosis further increases cardio-cerebrovascular risk in type 2 diabetes. Cardiovasc Diabetol (2016) 0.75
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Banting lecture 1988. Role of insulin resistance in human disease. Diabetes (1988) 33.22
Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA (2002) 25.68
Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med (1999) 16.30
Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation (1997) 7.03
Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study. J Am Coll Cardiol (2010) 5.79
Screening asymptomatic subjects for subclinical atherosclerosis: can we, does it matter, and should we? J Am Coll Cardiol (2010) 3.16
Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol (2004) 2.91
Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care (2002) 2.69
Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol (1991) 2.54
Effects of childhood primary hypertension on carotid intima media thickness: a matched controlled study. Hypertension (2006) 2.33
Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation (1993) 2.31
Asymptomatic carotid lesions and aging: Role of hypertension and other traditional and emerging risk factors. Arch Med Res (2006) 2.03
Carotid atherosclerosis is a stronger predictor of myocardial infarction in women than in men: a 6-year follow-up study of 6226 persons: the Tromsø Study. Stroke (2007) 1.93
Impact of multiple coronary risk factors on the intima-media thickness of different segments of carotid artery in healthy young adults (The Bogalusa Heart Study). Am J Cardiol (2002) 1.88
Increase in carotid intima-media thickness in grade I hypertensive subjects: white-coat versus sustained hypertension. Hypertension (2008) 1.74
Increased subclinical atherosclerosis in young adults with metabolic syndrome: the Bogalusa Heart Study. J Am Coll Cardiol (2005) 1.50
Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome (The ARIC Study). Am J Cardiol (2004) 1.49
Carotid artery intima-media thickness in patients with Type 2 diabetes mellitus and impaired glucose tolerance: a systematic review. Diabet Med (2006) 1.43
Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke (1996) 1.41
Atherosclerosis in childhood and adolescent type 1 diabetes: early disease, early treatment? Diabetologia (2005) 1.33
Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: the cardiovascular risk in young Finns study. Circulation (2009) 1.33
Intima media thickness as a surrogate marker for generalised atherosclerosis. Cardiovasc Drugs Ther (2002) 1.30
Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J (2009) 1.26
Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol (2007) 1.26
Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke (2005) 1.06
The metabolic syndrome and progression of carotid atherosclerosis over 13 years. The Tromsø study. Cardiovasc Diabetol (2012) 1.02
Uric acid level and its association with carotid intima-media thickness in patients with hypertension. Atherosclerosis (2007) 1.02
Measurement of intima-media thickness of common carotid arteries with high-resolution B-mode ultrasonography: inter- and intra-observer variability. Ultrasound Med Biol (1991) 1.00
Low cerebral blood flow is associated with lower memory function in metabolic syndrome. Obesity (Silver Spring) (2013) 0.99
Metabolic syndrome and carotid intima media thickness in the Health 2000 Survey. Atherosclerosis (2008) 0.97
Metabolic syndrome may be a risk factor for early carotid atherosclerosis in women but not in men. J Atheroscler Thromb (2007) 0.97
Previous gestational diabetes is independently associated with increased carotid intima-media thickness, similarly to metabolic syndrome - a case control study. Cardiovasc Diabetol (2012) 0.92
Subclinical atherosclerosis: evolving role of carotid intima-media thickness. Prev Cardiol (2010) 0.92
Homocysteine and carotid intima-media thickness in a german population: lack of clinical relevance. Stroke (2006) 0.91
Early signs of atherosclerosis are associated with insulin resistance in non-obese adolescent and young adults with type 1 diabetes. Cardiovasc Diabetol (2012) 0.91
Metabolic syndrome (MetS) predicts cardio and cerebrovascular events in a twenty years follow-up. A prospective study. Atherosclerosis (2012) 0.88
Association between birth weight and cardiovascular risk factors in adolescents. Arq Bras Cardiol (2013) 0.84
Association between presence of the metabolic syndrome and its components with carotid intima-media thickness and carotid and femoral plaque area: a population study. Diabetol Metab Syndr (2013) 0.83
Asymptomatic carotid lesions add to cardiovascular risk prediction. Eur J Cardiovasc Prev Rehabil (2010) 0.82
Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol. Atherosclerosis (2008) 0.82
The metabolic syndrome: definition, diagnosis and management. Int Angiol (2008) 0.82
Preclinical carotid atherosclerosis enhances the global cardiovascular risk and increases the rate of cerebro- and cardiovascular events in a five-year follow-up. Atherosclerosis (2010) 0.80
Markers of inflammation and prevalence of vascular disease in patients with metabolic syndrome. Int Angiol (2007) 0.77
[Takotsubo cardiomyopathy: a consensus document]. G Ital Cardiol (Rome) (2008) 2.26
Asymptomatic carotid lesions and aging: Role of hypertension and other traditional and emerging risk factors. Arch Med Res (2006) 2.03
Impact of moderate ischemic mitral regurgitation after isolated coronary artery bypass grafting. Ann Thorac Surg (2010) 1.77
Chronic pharmacological treatment in takotsubo cardiomyopathy. Int J Cardiol (2007) 1.73
Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions. Menopause (2008) 1.44
An update on the role of markers of inflammation in atherosclerosis. J Atheroscler Thromb (2009) 1.44
Neuromuscular disorders and non compaction: how much is the strength of the association and how can it be suspected? Int J Cardiol (2008) 1.39
Asymptomatic ventricular pre-excitation in children. J Cardiovasc Med (Hagerstown) (2009) 1.39
Segmental dyskinesia in Wolff-Parkinson-White syndrome: a possible cause of dilatative cardiomyopathy. Int J Cardiol (2007) 1.18
Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study. Stroke (2005) 1.06
Cardiopulmonary Exercise Testing in Patients with Chronic Heart Failure: Prognostic Comparison from Peak VO2 and VE/VCO2 Slope. Open Cardiovasc Med J (2010) 0.95
Anticoagulant drugs in noncompaction: a mandatory therapy? J Cardiovasc Med (Hagerstown) (2008) 0.95
Endothelial dysfunction and carotid lesions are strong predictors of clinical events in patients with early stages of atherosclerosis: a 24-month follow-up study. Coron Artery Dis (2008) 0.94
Association of elevated fibrinogen and C-reactive protein levels with carotid lesions in patients with newly diagnosed hypertension or type II diabetes. Arch Med Res (2006) 0.93
Contrast-induced nephropathy after percutaneous coronary intervention in simple lesions: risk factors and incidence are affected by the definition utilized. Intern Med (2011) 0.92
Magnetic resonance in isolated noncompaction of the ventricular myocardium. Int J Cardiol (2008) 0.87
Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis. Stroke (2005) 0.84
The PFO anatomy evaluation as possible tool to stratify the associated risks and the benefits arising from the closure. Eur J Echocardiogr (2010) 0.84
Atherosclerosis, inflammation and Chlamydia pneumoniae. World J Cardiol (2009) 0.84
Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM. Int J Cardiol (2006) 0.83
Helicobacter pylori and atrial fibrillation: absence of correlations. J Cardiovasc Med (Hagerstown) (2009) 0.83
Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension. Coron Artery Dis (2009) 0.83
Asymptomatic carotid lesions add to cardiovascular risk prediction. Eur J Cardiovasc Prev Rehabil (2010) 0.82
Prediction of cardio- and cerebro-vascular events in patients with subclinical carotid atherosclerosis and low HDL-cholesterol. Atherosclerosis (2008) 0.82
Women and peripheral arterial disease: same disease, different issues. J Cardiovasc Med (Hagerstown) (2008) 0.82
An unusual cause of cerebral cardioembolism in a 33-year-old man due to ventricular noncompaction. Neurologist (2009) 0.81
Chest pain due to late huge coronary pseudoaneurysm following stent implantation. Intern Med (2011) 0.81
Supraventricular arrhythmias in noncompaction of left ventricle: is this a frequent complication? Int J Cardiol (2007) 0.81
Preclinical carotid atherosclerosis enhances the global cardiovascular risk and increases the rate of cerebro- and cardiovascular events in a five-year follow-up. Atherosclerosis (2010) 0.80
Timely recognition of cardiovascular toxicity by anticancer agents: a common objective of the pharmacologist, oncologist and cardiologist. Cardiovasc Toxicol (2012) 0.80
In-hospital complications of acute myocardial infarction in hypertensive subjects. Am J Hypertens (2005) 0.80
Prediction of cerebrovascular and cardiovascular events in patients with subclinical carotid atherosclerosis: the role of C-reactive protein. J Investig Med (2008) 0.80
Left ventricular non-compaction cardiomyopathy in children: Is segmental fibrosis the cause of tissue Doppler alterations and of EF reduction? Int J Cardiol (2008) 0.80
Transient mid-ventricular dyskinesia: a variant of Takotsubo syndrome. Int J Cardiol (2007) 0.79
Impact of dual antiplatelet therapy with proton pump inhibitors on the outcome of patients with acute coronary syndrome undergoing drug-eluting stent implantation. ISRN Cardiol (2012) 0.79
Chemotherapy-induced cardiotoxicity: role of the tissue Doppler in the early diagnosis of left ventricular dysfunction. Anticancer Drugs (2011) 0.79
Improving the preclinical models for the study of chemotherapy-induced cardiotoxicity: a Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection. Heart Fail Rev (2015) 0.79
Association between asymptomatic carotid atherosclerosis and degenerative aortic stenosis. Atherosclerosis (2012) 0.78
Ventricular dysfunction and number of non compacted segments in non compaction: non-independent predictors. Int J Cardiol (2009) 0.78
Multiplane two-dimensional versus real time three-dimensional transesophageal echocardiography in ischemic mitral regurgitation. Echocardiography (2011) 0.78
Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: the extended DACUS study. Am J Hematol (2011) 0.78
[Cardiovascular risk profile of patients with psoriasis]. Recenti Prog Med (2013) 0.78
Cardiac involvement in patients with cirrhosis: a focus on clinical features and diagnosis. J Cardiovasc Med (Hagerstown) (2016) 0.78
Noncompaction of the right ventricle. Pediatr Cardiol (2010) 0.78
Prognostic role of aldosterone in patients with acute coronary syndrome: short and medium term follow-up. J Cardiovasc Med (Hagerstown) (2014) 0.77
Real-world use of ticagrelor and prasugrel in patients with NSTEMI undergoing percutaneous coronary intervention. J Cardiovasc Med (Hagerstown) (2017) 0.77
[Association of carotid atherosclerosis with coronary artery disease: comparison between carotid ultrasonography and coronary angiography in patients with chest pain]. G Ital Cardiol (Rome) (2012) 0.77
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy. Expert Opin Drug Saf (2014) 0.77
Independent Impact of RV Involvement on In-Hospital Outcome of Patients With Takotsubo Syndrome. JACC Cardiovasc Imaging (2015) 0.77
Evaluation of diastolic function by the Tissue doppler in children affected by non-compaction. Int J Cardiol (2007) 0.77
Peripheral atherosclerosis is associated with the occurrence of restenosis after percutaneous coronary intervention. Coron Artery Dis (2007) 0.77
Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: role of echocardiography. J Cardiovasc Med (Hagerstown) (2016) 0.76
Pharmacological treatment of patients with chronic critical limb ischemia: L-propionyl-carnitine enhances the short-term effects of PGE-1. Cardiovasc Drugs Ther (2009) 0.76
[Diagnosis of coronary microvascualar dysfunction in diabetic patients with cardiac syndrome X: comparison by current methods]. Recenti Prog Med (2013) 0.76
Risk factors for contrast induced nephropathy: a study among Italian patients. Indian Heart J (2012) 0.76
Protrhombotic effects of contraceptives. Curr Pharm Des (2010) 0.76
Patent foramen ovale and thromboembolic complications. Curr Pharm Des (2010) 0.76
Statin therapy in patients with aortic stenosis after the ASTRONOMER trial: is there still any space? Intern Emerg Med (2011) 0.76
Circulating transforming growth factor-beta1 levels in asymptomatic carotid plaques. Stroke (2005) 0.75
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology. J Cardiovasc Med (Hagerstown) (2016) 0.75
Isolated left ventricular non-compaction: a larger part of submerged iceberg with criteria for diagnosis to the limits of standard. Int J Cardiol (2009) 0.75
Delayed MRI hyperenhancement in noncompaction: sign of fibrosis correlated with clinical severity. AJR Am J Roentgenol (2008) 0.75
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology. J Cardiovasc Med (Hagerstown) (2016) 0.75
Early subclinical ventricular dysfunction in patients with insulin resistance. J Cardiovasc Med (Hagerstown) (2014) 0.75
Reduced regional systolic function evolved compacted segments in noncompaction. Int J Cardiol (2009) 0.75
Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology. J Cardiovasc Med (Hagerstown) (2016) 0.75
Mediterranean diet impact on cardiovascular diseases: a narrative review. J Cardiovasc Med (Hagerstown) (2017) 0.75
Thrombus-like small apical fibroma in patient with left ventricular dysfunction and thrombophilia: an unusual presentation. J Cardiovasc Med (Hagerstown) (2016) 0.75
Heart rate turbulence for guiding electric therapy in patients with cardiac failure. J Clin Monit Comput (2010) 0.75
Cardiovascular magnetic resonance characterization of a hamartoma in an asymptomatic child. Int J Cardiol (2007) 0.75
Pathophysiology of anthracycline cardiotoxicity. J Cardiovasc Med (Hagerstown) (2016) 0.75
[Metabolic syndrome in children and in adults: is it an autonomous nosological entity?]. Recenti Prog Med (2012) 0.75
Chemotherapy cardiotoxicity: cardioprotective drugs and early identification of cardiac dysfunction. J Cardiovasc Med (Hagerstown) (2016) 0.75
Treatment of Tako-tsubo cardiomyopathy. Int J Cardiol (2007) 0.75
A rare case of Prinzmetal angina 3 days after coronary artery stenting with a second-generation drug-eluting stent. Coron Artery Dis (2015) 0.75
Diagnosis and definition of biventricular non-compaction associated to Ebstein's anomaly. Int J Cardiol (2009) 0.75
Pathophysiology of anthracycline cardiotoxicity. J Cardiovasc Med (Hagerstown) (2016) 0.75
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology. J Cardiovasc Med (Hagerstown) (2016) 0.75
Obesity: a new pathology to pay attention to in young people. Curr Pharm Des (2010) 0.75
Tako-tsubo cardiomyopathy and microcirculation. J Clin Monit Comput (2010) 0.75
Large left ventricular metastasis in patient with liposarcoma. J Cardiovasc Med (Hagerstown) (2016) 0.75
The role of statins in preventing the progression of congestive heart failure in patients with metabolic syndrome. Curr Pharm Des (2008) 0.75
Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: role of echocardiography. J Cardiovasc Med (Hagerstown) (2016) 0.75
Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology. J Cardiovasc Med (Hagerstown) (2016) 0.75
Prognosis in patients with microvascular angina: a clinical follow-up. J Cardiovasc Med (Hagerstown) (2019) 0.75
The association between the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor-1 gene and extension of postsurgical calf vein thrombosis. Blood Coagul Fibrinolysis (2013) 0.75
[Cardiorenal syndrome: the role of new biochemical markers]. Recenti Prog Med (2012) 0.75
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology. J Cardiovasc Med (Hagerstown) (2016) 0.75
A cardiac fibroma in a 7-year-old asymptomatic girl admitted for ECG anomalies. J Cardiovasc Med (Hagerstown) (2012) 0.75
Thrombotic complications during overt hyperthyroidism. Intern Emerg Med (2012) 0.75
Analysis of N-terminal pro-B-type natriuretic peptide in patients with acute coronary syndromes. Coron Artery Dis (2009) 0.75